choline magnesium trisalicylate
Selected indexed studies
- Choline Magnesium Salicylate. (, 2006) [PMID:30000947]
- Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy. (Leuk Lymphoma, 2017) [PMID:27659510]
- Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity. (Drug Intell Clin Pharm, 1987) [PMID:3301251]
_Worker-drafted node — pending editorial review._
Connections
choline magnesium trisalicylate is a side effect of
Sources
- Choline Magnesium Salicylate. (2006) pubmed
- Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy. (2017) pubmed
- Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity. (1987) pubmed
- Trisalicylate. (2012) pubmed
- Choline magnesium trisalicylate in patients with aspirin-induced asthma. (1990) pubmed
- Effect of choline magnesium trisalicylate on prostacyclin production by isolated vascular tissue of the rat. (1983) pubmed
- A comparison of choline magnesium trisalicylate and acetylsalicylic acid in patients with rheumatoid arthritis. (1990) pubmed
- Choline magnesium trisalicylate: comparative pharmacokinetic study of once-daily and twice-daily dosages. (1984) pubmed
- Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis. (1980) pubmed
- Choline magnesium trisalicylate does not impair platelet aggregation. (1981) pubmed